Testosterone-related shortening of QTc interval in women with polycystic ovary syndrome

Journal of Endocrinological Investigation

Volumn 31, Issue 7, 2008, Pages 653-655

  Vrtovec, B ^a   Meden Vrtovec, H ^a   Jensterle, M ^a   Radovancevic, B ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Polycystic ovary syndrome; QTc interval; Testosterone

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIN 1; INSULIN; TESTOSTERONE;

ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FEMALE INFERTILITY; HUMAN; MAJOR CLINICAL STUDY; OLIGOMENORRHEA; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PROTEIN BLOOD LEVEL; SHORT QT INTERVAL; TESTOSTERONE BLOOD LEVEL; TREATMENT FAILURE;

EID: 54949156805     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345619     Document Type: Article

References (11)

1. Ehrmann DA. Polycystic ovary sydrome. N Engl J Med 2005, 352: 1223-36.
2. Vryonidou A, Papatheodorou A, Tavridou A, et al. Association of hyperandrogenemic and metabolic phenotype with carotid intimamedia thickness in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005, 90: 2740-6.
3. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991, 84: 1516-23.
4. Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 1993, 270: 2590-7.
5. Alpaslan M, Onrat E, Yilmazer M, Fenkci V. QT dispersion in patients with polycystic ovary syndrome. Jpn Heart J 2002, 43: 487-93.
6. Nowinski K, Pripp U, Carlström K, Landgren BM, Schenck-Gustafsson K, Bergfeldt L. Repolarization measures and their relation to sex hormones in postmenopausal women with cardiovascular disease receiving hormone replacement therapy. Am J Cardiol 2002, 90: 1050-5.
7. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004, 19: 41.
8. Toivonen L. More light on QT interval measurement. Heart 2002, 87: 193-4.
9. Diamanti-Kandarakis E, Alexandraki K, Piperi C, et al. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 2006, 36: 691-7.
10. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation 2005, 112: 1701-1.
11. Fülöp L, Bányász T, Szabó G, et al. Effects of sex hormones on ECG parameters and expression of cardiac ion channels in dogs. Acta Physiol 2006, 88: 163-71.